In addition to the role of HMGB1 in ICD, it was found that upon hypericin treatment of bladder cancer cells or upon oxaliplatin or doxyrubicin treatment high levels of ATP were secreted, which like calreticulin also preceded apoptotic PS exposure (50). The gene discussed is CALR; the disease is urinary bladder cancer.